bpc-157 for gut inflammation GLP-1s and Peptide Therapies: What You Should Know 🧬 BPC-157 Peptide Therapy |

For Metos audience, the key is this: AOD-9604 is not a replacement for GLP-1s

[2] 10mg Vial Specifications Sequence: Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val Molecular Formula: CHNO Molecular Weight: 1,419.5 Da Purity: 99% (third-party HPLC verified) Form: Lyophilized (freeze-dried) powder Vial Size: 10 mg Storage: 20 C (long-term)

These synthesis-dependent choices directly influence drug loading capacity, pH-responsive release, organelle targeting, and cellular uptake, highlighting that therapeutic efficacy arises from deliberate surface and structural engineering, rather than from the carbon core alone

Overall, at week 88, participants with 75% or more weight regain after tirzepatide withdrawal reversed cardiometabolic parameters to baseline (week 0) values, the team write, although they note those with up to 50% weight regain still showed improvements in these areas compared with the start of the study